B. Ji

发表

Effectiveness of Once-Weekly Rifapentine and Moxifloxacin Regimens against Mycobacterium tuberculosis in Mice

N. Lounis, Abdelhalim Bentoucha, C. Truffot-Pernot, 2001, Antimicrobial Agents and Chemotherapy.

In Vitro and In Vivo Activities of Moxifloxacin and Clinafloxacin against Mycobacterium tuberculosis

N. Lounis, C. Truffot-Pernot, B. Ji, 1998, Antimicrobial Agents and Chemotherapy.

In Vitro and In Vivo Activities of Rifampin, Streptomycin, Amikacin, Moxifloxacin, R207910, Linezolid, and PA-824 against Mycobacterium ulcerans

V. Jarlier, J. Robert, B. Ji, 2006, Antimicrobial Agents and Chemotherapy.

In vitro and in vivo activities of sparfloxacin (AT-4140) against Mycobacterium tuberculosis.

C. Truffot-Pernot, B. Ji, J. Grosset, 1991, Tubercle.

Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy

N. Lounis, C. Truffot-Pernot, B. Ji, 1992, Antimicrobial Agents and Chemotherapy.

Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens.

G. Hejblum, N. Lounis, C. Truffot-Pernot, 2000, American journal of respiratory and critical care medicine.

Clarithromycin is inactive against Mycobacterium tuberculosis

N. Lounis, C. Truffot-Pernot, B. Ji, 1995, Antimicrobial agents and chemotherapy.

Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex

C. Truffot-Pernot, B. Ji, J. Grosset, 1991, Antimicrobial Agents and Chemotherapy.

Efficacies of Clarithromycin Regimens against Mycobacterium xenopi in Mice

J. Robert, N. Lounis, Abdelhalim Bentoucha, 2001, Antimicrobial Agents and Chemotherapy.

Chemotherapy-Associated Changes of Histopathological Features of Mycobacterium ulcerans Lesions in a Buruli Ulcer Mouse Model

G. Pluschke, V. Jarlier, B. Ji, 2011, Antimicrobial Agents and Chemotherapy.

Impacts of interleukin-12 on multiplication of Mycobacterium tuberculosis and Mycobacterium avium complex in mice.

N. Lounis, C. Truffot-Pernot, B. Ji, 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model

N. Lounis, C. Truffot-Pernot, B. Ji, 1995, Antimicrobial agents and chemotherapy.

Prevention of the Selection of Clarithromycin-Resistant Mycobacterium avium-intracellulare Complex

B. Ji, J. Grosset, 2012, Drugs.

Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model

N. Lounis, C. Truffot-Pernot, B. Ji, 1994, Antimicrobial Agents and Chemotherapy.

Bactericidal Activities of R207910 and Other Newer Antimicrobial Agents against Mycobacterium leprae in Mice

K. Andries, V. Jarlier, B. Ji, 2006, Antimicrobial Agents and Chemotherapy.

How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?

N. Lounis, C. Truffot-Pernot, B. Ji, 1996, Antimicrobial agents and chemotherapy.

Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice.

P. Olliaro, C. Truffot-Pernot, B. Ji, 1993, The American review of respiratory disease.

Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy.

B. Ji, J. Grosset, P. Bobin, 1993, The Journal of infectious diseases.

Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin.

J. Cottin, L. Marsollier, G. Pluschke, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bactericidal and Sterilizing Activities of Several Orally Administered Combined Regimens against Mycobacterium ulcerans in Mice

V. Jarlier, J. Robert, B. Ji, 2008, Antimicrobial Agents and Chemotherapy.

Orally Administered Combined Regimens for Treatment of Mycobacterium ulcerans Infection in Mice

V. Jarlier, J. Robert, B. Ji, 2007, Antimicrobial Agents and Chemotherapy.

Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice

C. Truffot-Pernot, B. Ji, J. Grosset, 1993, Antimicrobial Agents and Chemotherapy.

In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis

N. Lounis, C. Truffot-Pernot, B. Ji, 1995, Antimicrobial agents and chemotherapy.

Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experiments.

C. Truffot-Pernot, B. Ji, J. Grosset, 1991, Tubercle.

Treatment of Leprosy

B. Ji, 1998 .

Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae

B. Ji, E. Cambau, I. Guillemin, 1997, The Lancet.

Bactericidal Activities of HMR 3647, Moxifloxacin, and Rifapentine against Mycobacterium leprae in Mice

Abdelhalim Bentoucha, B. Ji, J. Grosset, 2000, Antimicrobial Agents and Chemotherapy.

Bactericidal Activity of a Single-Dose Combination of Ofloxacin plus Minocycline, with or without Rifampin, against Mycobacterium leprae in Mice and in Lepromatous Patients

B. Ji, J. Grosset, C. Lienhardt, 1998, Antimicrobial Agents and Chemotherapy.

Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients

B. Ji, J. Grosset, C. Lienhardt, 1996, Antimicrobial agents and chemotherapy.

Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy

B. Ji, J. Grosset, E. Perani, 1994, Antimicrobial Agents and Chemotherapy.

Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy.

V. Jarlier, W. Sougakoff, B. Ji, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Towards an immunodiagnostic test for leprosy.

S. Cole, N. Honoré, Sang-Nae Cho, 2006, Microbes and infection.

Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice

B. Ji, J. Grosset, E. Perani, 1996, Antimicrobial agents and chemotherapy.

Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice

B. Ji, J. Grosset, E. Perani, 1991, Antimicrobial Agents and Chemotherapy.

Recent advances in the chemotherapy of leprosy.

B. Ji, J. Grosset, 1990, Leprosy review.

Models of Leprosy Infection in Mice

B. Ji, L. Levy, 1999 .

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice

C. Truffot-Pernot, B. Ji, J. Grosset, 1992, Antimicrobial Agents and Chemotherapy.

Drugs and regimens for preventive therapy against tuberculosis, disseminated Mycobacterium avium complex infection and leprosy.

B. Ji, J. Grosset, 1999, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice?

N. Lounis, C. Truffot-Pernot, B. Ji, 1997, Antimicrobial agents and chemotherapy.

Experimental Chemotherapy of Mycobacterial Diseases

B. Ji, J. Grosset, 1998 .

The mouse foot-pad technique for cultivation of Mycobacterium leprae.

B. Ji, L. Levy, 2006, Leprosy review.

Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice.

C. Truffot-Pernot, B. Ji, R. O'brien, 1994, American journal of respiratory and critical care medicine.

Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice.

N. Lounis, C. Truffot-Pernot, B. Ji, 1998, American journal of respiratory and critical care medicine.

Erratum: Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice (American Journal of Respiratory and Critical Care Medicine (1993) 148 (1541-1546))

P. Olliaro, C. Truffot-Pernot, B. Ji, 1994 .

Comparative activities of amikacin against Mycobacterium avium complex in nude and beige mice

N. Lounis, C. Truffot-Pernot, B. Ji, 1997, Antimicrobial agents and chemotherapy.

Rifampicin resistant leprosy: a review and a research proposal of a pilot study.

B. Ji, 2002, Leprosy review.

Impacts of Dosing Frequency of the Combination Rifampin-Streptomycin on Its Bactericidal and Sterilizing Activities against Mycobacterium ulcerans in Mice

V. Jarlier, J. Robert, B. Ji, 2009, Antimicrobial Agents and Chemotherapy.

Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.

B. Ji, J. Grosset, E. Perani, 1992, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

Further study of the effectiveness of single doses of clarithromycin and minocycline against Mycobacterium leprae in mice.

B. Ji, J. Grosset, E. Perani, 1994, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy.

B. Ji, J. Grosset, 2000, Leprosy review.

Are Variable-Number Tandem Repeats Appropriate for Genotyping Mycobacterium leprae?

S. Cole, N. Honoré, P. Brennan, 2008, Journal of Clinical Microbiology.

Impacts of Dosing Frequency of the Combination Rifampin-Streptomycin on Its Bactericidal and Sterilizing Activities against Mycobacterium ulcerans in Mice

V. Jarlier, J. Robert, B. Ji, 2009, Antimicrobial Agents and Chemotherapy.